
zzso zzso and its complications are major zzso zzso of cancer zzso The zzso growth factors have been shown to reduce the risk of zzso events across zzso regimens, and associated risk categories often enabling the delivery of greater chemotherapy dose zzso Three different practice guidelines for the zzso growth factors have recently been published by major professional zzso A comprehensive review and comparison of the guidelines using a zzso structured content criteria and a previously validated quality appraisal tool are zzso zzso in the final recommendations from these guidelines is observed for primary prophylaxis with the zzso factors zzso when the risk of zzso zzso is in the range of zzso or zzso There is also consistency in the recommendation that patients receiving regimens associated with lower risk should have zzso use guided by individual risk zzso Critical quality appraisal indicates that the scope and purpose, stakeholder involvement, and zzso of the guidelines differ zzso There is more emphasis on comprehensive literature reviews in the zzso and zzso guidelines while the zzso guidelines are more current based on systematic annual zzso The clarity of presentation also favors the zzso guidelines with recommendations generally presented as both text and zzso zzso All three new or updated guidelines recommend zzso use of the zzso growth factors in patients at greater than a zzso risk of zzso zzso and in those with important factors increasing individual risk of zzso zzso 

